Exploring the Role of Gut Microbiota Modulation in Enhancing Oral Bioavailability of Poorly Soluble Drugs
Abstract
To investigate the effect of gut microbiota modulation at a target location on oral bioavailability of poorly soluble drugs using probiotics, prebiotics, and synbiotic therapy. A double-blind, randomized, placebo-controlled study was conducted in 120 healthy volunteers who were divided into four intervention groups: control, probiotic (Lactobacillus rhamnosus GG and Bifidobacterium longum), prebiotic (inulin and fructooligosaccharides), and synbiotic therapy. Participants received a standardized dose of three poorly soluble model drugs (simvastatin, curcumin, and quercetin) before and after 28 days of intervention. Plasma drug levels, gut microbiota composition (16S rRNA sequencing), and microbial metabolites were measured.
Letters in High Energy Physics (LHEP) is an open access journal. The articles in LHEP are distributed according to the terms of the creative commons license CC-BY 4.0. Under the terms of this license, copyright is retained by the author while use, distribution and reproduction in any medium are permitted provided proper credit is given to original authors and sources.
Terms of Submission
By submitting an article for publication in LHEP, the submitting author asserts that:
1. The article presents original contributions by the author(s) which have not been published previously in a peer-reviewed medium and are not subject to copyright protection.
2. The co-authors of the article, if any, as well as any institution whose approval is required, agree to the publication of the article in LHEP.